Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients with Neovascular Age-related Macular Degeneration.
Patients are randomised to 12, 8 or 4 weekly treatment.
Trial registry no: NCT02462486
A not for profit organisation
A not for profit organisation
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients with Neovascular Age-related Macular Degeneration.
Patients are randomised to 12, 8 or 4 weekly treatment.
Trial registry no: NCT02462486
If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.
